At Lumiere Tax, we are happy to advise on the difficult questions and the areas of UK tax others shy away from. We seek HMRC clearance whenever possible, but when it is not we will set out your options, get off the fence and give our view on the best and most practical way forwards.
Critical to our approach is keeping due diligence in mind for when a sale or investment is forthcoming and making sure any tax risks are minimised and transparent.
All our work is bespoke and we encourage you to pick up the phone and chat through your needs so we can offer you tailored advice on an individual basis.
The team is always happy to answer questions so please do get in touch.
We typically charge on a fixed-fee basis and we do not seek to bill ‘overruns’. This means you can accrue our fees upfront and have future certainty over our costs.
We advise on all the difficult parts of the UK tax system relevant to biotech and tech companies, including R&D tax credits, the patent box and demergers and share and IP valuations.
We offer advice on which types of scheme is best suited to your company, value the shares and deal with the more difficult aspects of UK tax law. We can help unpick problems to maximise value for management teams and minimise payroll tax costs for the company.
We are happy to help you through the due diligence process, to shut down tax issues and help you get the deal done. We can advise on all the UK tax issues that come up in the process of selling a biotech or tech company.
We provide UK tax due diligence services to venture capital firms that are planning investments. Our work includes corporation tax, R&D tax credits, employee taxes, employee share schemes, VAT and withholding tax.
Meet our dedicated team of tax professionals, delivering unparalleled expertise in the biotech and life sciences sectors.
Have questions or need assistance? We’re here to help.
Reach out to us via email, and one of our experts
will get back to you shortly.
